NIH-funded research NIH-funded research

Alzheimer's and related dementia risk in people with prediabetes and type 2 diabetes

Official title: Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Funded at Columbia University Health Sciences · NIH-11367296 · Data updated 2026-11-12

This project looks at brain changes, memory, medications, and health measures in older adults with prediabetes or type 2 diabetes to find what leads to dementia.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2025
Award (this year)$15,462,979
NIH project number5U19AG078558-04
Project IDNIH-11367296 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are older adults (most participants are 65+) with a history of prediabetes or type 2 diabetes, especially those already enrolled in the Diabetes Prevention Program Outcomes Study.

Less likely to help

People without prediabetes or type 2 diabetes, much younger adults, or those whose memory problems are due to other known causes may not see direct benefits from this research.

What this research studies

If you take part, researchers will work with people from the long-running Diabetes Prevention Program Outcomes Study, most of whom are age 65 and older. You would have memory tests, blood tests for glucose, insulin, and Alzheimer’s markers, brain imaging, and detailed records of medications such as metformin, physical activity, and measures of frailty. The team will combine these tests to see which factors — including blood sugar control, medications, vascular changes, and physical function — relate to cognitive decline. Some projects will also link clinical measures to brain pathology and other dementia markers to better understand underlying causes.

Why it matters

Potential benefit: If successful, this work could point to ways to prevent or slow dementia in people with prediabetes or type 2 diabetes by identifying modifiable risk factors and treatment targets.

How similar studies have gone: Previous studies have linked diabetes to higher dementia risk and used imaging and biomarkers, but combining deep diabetes phenotyping, medication effects like metformin, and AD pathology across a large older cohort is relatively novel.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Luchsinger, Jose Alejandro — Columbia University Health Sciences
  • Study coordinator: Luchsinger, Jose Alejandro

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.